Sponsored by ActivX Biosciences, the Dana-Farber Cancer Institute, Merck Research Laboratories, New England Biolabs Inc., Organon, and Peptimmune Inc., the daylong symposium (9 a.m. to 5 p.m.) will feature professors from Harvard, the Massachusetts Institute of Technology, and Stanford, among other institutions. Topics include “The Clonal Selection Hypothesis Revisited” and “On Unintelligent Design.”
This symposium is open to the public. Free parking is available at the New Research Building.
For further information, contact Julia Blackbourn at juliab@mcb.harvard.edu.